AGP Executive Report
Last update: 2 hours agoClinical Trials in Focus: A BEGONIA phase 1b/2 study reports trastuzumab deruxtecan plus durvalumab shrinking tumors in about six in ten women with hormone-receptor-negative, HER2-low metastatic breast cancer, with benefits still ongoing for many. Cardiology Update: The PVI-SHAM-AF trial at ESC Congress 2026 finds catheter ablation for atrial fibrillation did not significantly improve AF-related quality of life versus a sham procedure, even though it reduced AF recurrence. Coronary Care Research: Polish-led VISION-FFR work compares vFFR with optical coherence tomography in chronic coronary syndromes, aiming to better match functional assessment with plaque detail. Health System Watch: New U.S. Medicaid spending data show Poland’s Medicaid “Medicine Services and Procedures” claims rising to $23,574 in 2024 (up 101.3% year-on-year), alongside Warsaw dental services reaching $311,532 in 2024. Public Health Angle: A bird flu report warns backyard bird feeding can spread H5N1, highlighting gaps in wildlife protection as outbreaks expand. Workforce & Access: A Polish-based story highlights a foreign-trained doctor’s path back into medicine after detention and emigration, including Polish language and diploma recognition hurdles.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
